# Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-tolerability-of-mk-0974-telcagepant-a-new-oral-antagonist-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tony W. Ho,Michel D. Ferrari,David W. Dodick,Vince Galet,James Kost,Xiaoyin Fan,Heather Leibensperger,Samar Froman,Christopher Assaid,Christopher Lines,Hille Koppen,Paul Winner |
| Citations | 531 |
| DOI | 10.1016/s0140-6736(08)61626-8 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2135858080 |
| PMID | 19036425 |
| Type | article |
| Year | 2008 |

## Paper authors

- [David W. Dodick](https://scholariq.org/researchers/david-w-dodick/)
- [Paul Winner](https://scholariq.org/researchers/paul-winner/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)

## Paper topics

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Pain Management and Opioid Use](https://scholariq.org/topics/pain-management-and-opioid-use/)
- [Traumatic Brain Injury and Neurovascular Disturbances](https://scholariq.org/topics/traumatic-brain-injury-and-neurovascular-disturbances/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.